Difference between revisions of "PMID:24837471"

From OMPwiki
(New PMID: Page!)
 
(Fill PMID: Page!)
 
Line 1: Line 1:
PMID on Demand placeholder
+
{{RightTOC}}
 +
 
 +
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.14165.X583f32339b0d7-->
 +
<!--
 +
******************************************************************************************
 +
*
 +
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
 +
*
 +
****************************************************************************************** -->
 +
{|  id="X583f32339b0d7"  class=" tableEdit PMID_info_table" 
 +
 
 +
|-
 +
!align=left align='left' bgcolor='#CCCCFF' |Citation
 +
||
 +
'''Lee, JH, Kim, YG, Cho, HS, Ryu, SY, Cho, MH and Lee, J''' Coumarins reduce biofilm formation and the virulence of Escherichia coli O157:H7. ''Phytomedicine'' '''21''':1037-42
 +
|-
 +
!align=left align='left' bgcolor='#CCCCFF' |Abstract
 +
||
 +
E. coli O157:H7 is the most common cause of hemorrhagic colitis, and no effective therapy exists for E. coli O157:H7 infection. Biofilm formation is closely related to E. coli O157:H7 infection and constitutes a mechanism of antimicrobial resistance. Hence, the antibiofilm or antivirulence approach provides an alternative to antibiotic strategies. Coumarin and its derivatives have a broad range of biological effects, and in this study, the antibiofilm activities of nine coumarins were investigated against E. coli O157:H7. Coumarin or umbelliferone at 50μg/ml was found to inhibit biofilm E. coli O157:H7 formation by more than 80% without affecting bacterial growth. Transcriptional analysis showed that coumarins repressed curli genes and motility genes in E. coli O157:H7, and these findings were in-line with observed reductions in fimbriae production, swarming motility, and biofilm formation. In addition, esculetin repressed Shiga-like toxin gene stx2 in E. coli O157:H7 and attenuated its virulence in vivo in the nematode Caenorhabditis elegans. These findings show that coumarins have potential use in antivirulence strategies against persistent E. coli O157:H7 infection.
 +
|-
 +
!align=left align='left' bgcolor='#CCCCFF' |Links
 +
||
 +
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=24837471 PubMed]
 +
Online version:[http://dx.doi.org/10.1016/j.phymed.2014.04.008 10.1016/j.phymed.2014.04.008]
 +
|-
 +
!align=left align='left' bgcolor='#CCCCFF' |Keywords
 +
||
 +
Animals; Anti-Bacterial Agents/pharmacology; Biofilms/drug effects; Biofilms/growth & development; Caenorhabditis elegans/drug effects; Coumarins/pharmacology; Escherichia coli O157/drug effects; Escherichia coli O157/pathogenicity; Escherichia coli O157/physiology; Escherichia coli O157/ultrastructure; Gene Expression Profiling; Gene Expression Regulation, Bacterial/drug effects; Umbelliferones/pharmacology; Virulence/drug effects
 +
 
 +
|- class="tableEdit_footer"
 +
|<div class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.14165.X583f32339b0d7&page=14165&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</div> ||
 +
|}
 +
<noinclude>
 +
<!-- OMP category tags -->
 +
</noinclude>
 +
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.14165.X583f32339b0d7-->
 +
 
 +
==Main Points of the Paper ==
 +
{{LitSignificance}}
 +
 
 +
== Materials and Methods Used ==
 +
{{LitMaterials}}
 +
 
 +
==Phenotype Annotations==
 +
{{AnnotationTableHelp}}
 +
<protect><!--box uid=d41d8cd98f00b204e9800998ecf8427e.14165.E583f3233af223-->
 +
<!--
 +
******************************************************************************************
 +
*
 +
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
 +
*
 +
****************************************************************************************** -->
 +
{| border="2" cellpadding="4" cellspacing="0" style="margin: 1em 1em 1em 0; border: 1px #aaa solid; border-collapse: collapse;"  id="E583f3233af223"  class=" tableEdit Phenotype_Table_2" 
 +
|- align='left' bgcolor='#CCCCFF'
 +
!|Phenotype of!!Taxon Information!!Genotype Information (if known)!!Condition Information!!OMP ID!!OMP Term Name!!ECO ID!!ECO Term Name!!Notes!!Status
 +
 
 +
|- class="tableEdit_footer"
 +
|<div class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.14165.E583f3233af223&page=14165&pagename={{FULLPAGENAMEE}}&type=0&template=Phenotype_Table_2 edit table]</div> || || || || || || || || ||
 +
|}
 +
<noinclude>
 +
<!-- OMP category tags -->
 +
</noinclude>
 +
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.14165.E583f3233af223--></protect>
 +
 
 +
==Notes==
 +
 
 +
==References==
 +
{{RefHelp}}
 +
<references/>
 +
 
 +
 
 +
[[Category:Publication]]

Latest revision as of 15:10, 30 November 2016

Citation

Lee, JH, Kim, YG, Cho, HS, Ryu, SY, Cho, MH and Lee, J Coumarins reduce biofilm formation and the virulence of Escherichia coli O157:H7. Phytomedicine 21:1037-42

Abstract

E. coli O157:H7 is the most common cause of hemorrhagic colitis, and no effective therapy exists for E. coli O157:H7 infection. Biofilm formation is closely related to E. coli O157:H7 infection and constitutes a mechanism of antimicrobial resistance. Hence, the antibiofilm or antivirulence approach provides an alternative to antibiotic strategies. Coumarin and its derivatives have a broad range of biological effects, and in this study, the antibiofilm activities of nine coumarins were investigated against E. coli O157:H7. Coumarin or umbelliferone at 50μg/ml was found to inhibit biofilm E. coli O157:H7 formation by more than 80% without affecting bacterial growth. Transcriptional analysis showed that coumarins repressed curli genes and motility genes in E. coli O157:H7, and these findings were in-line with observed reductions in fimbriae production, swarming motility, and biofilm formation. In addition, esculetin repressed Shiga-like toxin gene stx2 in E. coli O157:H7 and attenuated its virulence in vivo in the nematode Caenorhabditis elegans. These findings show that coumarins have potential use in antivirulence strategies against persistent E. coli O157:H7 infection.

Links

PubMed Online version:10.1016/j.phymed.2014.04.008

Keywords

Animals; Anti-Bacterial Agents/pharmacology; Biofilms/drug effects; Biofilms/growth & development; Caenorhabditis elegans/drug effects; Coumarins/pharmacology; Escherichia coli O157/drug effects; Escherichia coli O157/pathogenicity; Escherichia coli O157/physiology; Escherichia coli O157/ultrastructure; Gene Expression Profiling; Gene Expression Regulation, Bacterial/drug effects; Umbelliferones/pharmacology; Virulence/drug effects


Main Points of the Paper

Please summarize the main points of the paper.

Materials and Methods Used

Please list the materials and methods used in this paper (strains, plasmids, antibodies, etc).

Phenotype Annotations

See Help:AnnotationTable for details on how to edit this table.

Phenotype of Taxon Information Genotype Information (if known) Condition Information OMP ID OMP Term Name ECO ID ECO Term Name Notes Status


Notes

References

See Help:References for how to manage references in OMPwiki.